Skip to main content
SpringerLink
Log in

Pharmaceutical expenditure and therapeutic value of new medicines in Spain

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. The pharmaceutical industry in figures [in Spanish]. Madrid: Farmaindustria, 2001

  2. General directorate of pharmacy. Summary of scripts. Years 1997, 1998, 1999, 2000, 2001 [in Spanish]. Años: Ministry of Health and Consumption, 1997, 1998, 1999, 2000, 2001

  3. Therapeutic information of the National Health System. Madrid: Ministry of Health and Consumption, 2001

  4. Law 25/1990, 20th December 1990, Boletin Oficial del Estado, number 306

Download references

Acknowledgements

The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Centre for Health Economics, University of York, Heslington, York, UK

    Josep Darba

  2. University of Barcelona, Barcelona, Spain

    Josep Darba

Authors
  1. Josep Darba
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Darba, J. Pharmaceutical expenditure and therapeutic value of new medicines in Spain. Pharmacoeconomic 21, 1211–1212 (2003). https://doi.org/10.2165/00019053-200321160-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200321160-00005

Keywords

Search

Navigation